Dosimetric analysis of individual liver metastases from colorectal cancer following 90 y microsphere selective internal radiation therapy

Dosimetric analysis of individual liver metastases from colorectal cancer following 90 y microsphere selective internal radiation therapy

Colorectal cancer (CRC) is acommon cause of cancerrelated deaths (12.2% overall mortality, GLOBOCAN 2012 v1.0). Approximately half of CRC patients develop or present with metastasis (mCRC) to the liver. Selective internal radiation therapy (SIRT) involves injection of yttrium-90 (90Y) radiolabelledm...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Abbott, E, Falzone, N, Winter, H, Greenhalgh, T, Kartsonaki, C, Craig, A, Denis-Bacelar, A, Flux, G, Sharma, R, Vallis, K
Format:	Conference item
Wydane:	Elsevier 2017

Podobne zapisy

The impact of radiobiologically-informed dose prescription on the clinical benefit of yttrium-90 SIRT in colorectal cancer patients
od: Abbott, EM, i wsp.
Wydane: (2020)

Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
od: Lee, B, i wsp.
Wydane: (2019)

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
od: Sharma, R, i wsp.
Wydane: (2007)

Author reply: Radioembolization for colorectal liver metastases
od: Nicolay, N, i wsp.
Wydane: (2010)

Optimising radiotherapy of liver tumours: radiobiology of yttrium-90 microsphere treatment
od: Abbott, EM
Wydane: (2019)

Liver metastases from colorectal cancer: radioembolization with systemic therapy.
od: Nicolay, N, i wsp.
Wydane: (2009)

Hepatic artery chemotherapy and colorectal liver metastases.
od: Brooks, A, i wsp.
Wydane: (2003)

Hepatic artery chemotherapy and colorectal liver metastases - Reply
od: Kerr, D, i wsp.
Wydane: (2003)

Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver
od: Pwint, T, i wsp.
Wydane: (2010)

Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
od: Pwint, T, i wsp.
Wydane: (2010)

Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres
od: Winter, H, i wsp.
Wydane: (2019)

Synergy of yttrium-90 microspheres therapy with radiosensitising chemotherapy
od: Sharma, R
Wydane: (2012)

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
od: Stessels, F, i wsp.
Wydane: (2004)

Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003.
od: Chan, R, i wsp.
Wydane: (2004)

Monitoring circulating tumour DNA in patients receiving selective internal radiation therapy for liver metastases and intrahepatic cholangiocarcinoma
od: Winter, H, i wsp.
Wydane: (2016)

Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance
od: Buzzelli, J, i wsp.
Wydane: (2018)

Stereotactic body radiotherapy for liver metastases.
od: Aitken, K, i wsp.
Wydane: (2015)

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
od: Rahbari, N. N., i wsp.
Wydane: (2018)

FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer.
od: Sharma, R, i wsp.
Wydane: (2008)

Myofibroblast activation in colorectal cancer lymph node metastases.
od: Yeung, T, i wsp.
Wydane: (2013)

Monte Carlo evaluation of radionuclides for early brain metastases targeting
od: Falzone, N, i wsp.
Wydane: (2018)

Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases
od: Wang, L, i wsp.
Wydane: (2013)

WHAT IS THE TRUE INCIDENCE OF METACHRONOUS COLORECTAL LIVER METASTASES? EVIDENCE FROM THE UK FACS (FOLLOW-UP AFTER COLORECTAL SURGERY) TRIAL (ISRCTN: 41458548)
od: Pugh, S, i wsp.
Wydane: (2012)

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
od: Kerr, D, i wsp.
Wydane: (2003)

Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.
od: Wang, L, i wsp.
Wydane: (2013)

Stereotactic inverse dose planning following yttrium-90 selective internal radiotherapy in hepatocellular cancer
od: Abbott, EM, i wsp.
Wydane: (2020)

Clinical benefit and potential pitfalls in combining thermal ablation and radiation therapy to treat liver metastases.
od: Sharma, R, i wsp.
Wydane: (2013)

Bilious pleuritis following transpulmonary radiofrequency ablation of liver metastases
od: Kalin, A, i wsp.
Wydane: (2017)

Outcome of liver resection for small bowel neuroendocrine tumour metastases
od: Polkinghorne, MD, i wsp.
Wydane: (2018)

Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
od: Rockall, A, i wsp.
Wydane: (2009)

Production of uniform polymeric microspheres for liver tissue engineering
od: Loh, Dionne Hui Fang
Wydane: (2015)

The interaction between the Hypoxia Inducible Factor-1Α (HIF-1Α) and ERBB signalling pathways in colorectal liver metastases (CRLM)
od: Siriwardana, PN, i wsp.
Wydane: (2016)

Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis
od: Franklin, JM, i wsp.
Wydane: (2020)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy in an early brain metastasis model
od: Falzone, N, i wsp.
Wydane: (2018)

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
od: Lyon, P, i wsp.
Wydane: (2018)

Advanced brachytherapy dosimetric considerations
od: Melhus, Christopher S. (Christopher Scott), 1974-
Wydane: (2008)

Radioimmunotherapy for brain metastases: The potential for inflammation as a target of choice
od: Corroyer-Dulmont, A, i wsp.
Wydane: (2021)

MAGNETIC-MOMENTS OF Y-85-90 NUCLEI
od: Berkes, I, i wsp.
Wydane: (1988)

Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): Results from the FOXFIRE prospective randomized studies
od: Gray, A, i wsp.
Wydane: (2017)

Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases
od: Yuzhalin, A, i wsp.
Wydane: (2019)